CYBERMED LIFE - ORGANIC  & NATURAL LIVING

DISEASES

Synthesis and antiviral evaluation of 7-O-arylmethylquercetin derivatives against SARS-associated coronavirus (SCV) and hepatitis C virus (HCV).

Written by CYBERMED LIFE NEWS
Abstract Title:

Synthesis and antiviral evaluation of 7-O-arylmethylquercetin derivatives against SARS-associated coronavirus (SCV) and hepatitis C virus (HCV).

Abstract Source:

Arch Pharm Res. 2012 Jan ;35(1):77-85. Epub 2012 Feb 2. PMID: 22297745

Abstract Author(s):

Hye Ri Park, Hyunjun Yoon, Mi Kyoung Kim, Sung Dae Lee, Youhoon Chong

Article Affiliation:

Hye Ri Park

Abstract:

Aryl diketoacid (ADK) is well known for antiviral activity which can be enhanced by introduction of an aromatic arylmethyl substituent. A natural flavonoid quercetin has a 3,5-dihydroxychromone pharmacophore which is in bioisosteric relationship with the 1,3-diketoacid moiety of the ADK. Thus, it was of our interest to test the antiviral activity of the quercetin derivatives with an arylmethyl group attached. In this study, we prepared a series of the 7-O-arylmethylquercetin derivatives with various aromatic substituents and evaluated their antiviral activity against the SARS-associated coronavirus (SARS-CoV, SCV) as well as hepatitis C virus (HCV). Single difference in the aromatic substituent fine-tuned the biological activity of the 7-O-arylmethylquercetin derivatives to result in two different classes of derivatives selectively active against SCV and HCV.